Assignee
ARECOR LTD
GB·12 granted patents·36 pending applications·10 citations·filing 2006–2025
Top patents by PatentIndex Score
48 records- 0186US11278624B2FormulationsARECOR LTD·Filed 2017·Granted Mar 22, 2022·5 cites·24 claims
- 0279US2023068749A1Stabilization of aqueous compositions of proteins with displacement buffersARECOR LTD·Filed 2022·Application pending·0 cites
- 0377US11534402B2Liquid pharmaceutical compositionARECOR LTD·Filed 2018·Granted Dec 27, 2022·1 cites·25 claims
- 0474US2026077016A1Novel composition comprising antibodiesARECOR LTD·Filed 2025·Application pending·0 cites
- 0574US2020147206A1Stabilization of aqueous compositions of proteins with displacement buffersARECOR LTD·Filed 2019·Application pending·0 cites
- 0673US2025099593A1FormulationsARECOR LTD·Filed 2024·Application pending·0 cites
- 0772US9254332B2Stable aqueous formulations of adenovirus vectorsARECOR LTD·Filed 2014·Granted Feb 9, 2016·1 cites·23 claims
- 0871US10532098B2Stabilized aqueous antibody compositionsARECOR LTD·Filed 2013·Granted Jan 14, 2020·1 cites·26 claims
- 0971US2015071879A1Stabilization of Aqueous Compositions of Proteins with Displacement BuffersARECOR LTD·Filed 2014·Application pending·0 cites
- 1069US9023985B2Glucagon compositionARECOR LTD·Filed 2013·Granted May 5, 2015·2 cites·20 claims
- 1169US2025177501A1Aqueous solution compositions for increasing stability of engineered dimeric proteinsARECOR LTD·Filed 2024·Application pending·0 cites
- 1266US2023233463A1Liquid pharmaceutical compositionARECOR LTD·Filed 2022·Application pending·0 cites
- 1366US2023330014A1Liquid pharmaceutical compositionARECOR LTD·Filed 2022·Application pending·0 cites
- 1465US2022184213A1Novel formulationsARECOR LTD·Filed 2022·Application pending·0 cites
- 1563US2017202954A1Stabilization of Aqueous Compositions of Proteins With Displacement BuffersARECOR LTD·Filed 2017·Application pending·0 cites
- 1663US2025302735A1Injection pen system for the delivery of an insulin compoundARECOR LTD·Filed 2025·Application pending·0 cites
- 1762US12357562B2Injection pen system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Granted Jul 15, 2025·0 cites·54 claims
- 1862US12239685B2CompositionARECOR LTD·Filed 2019·Granted Mar 4, 2025·0 cites·15 claims
- 1961US12016922B2Stabilized aqueous antibody compositionsARECOR LTD·Filed 2019·Granted Jun 25, 2024·0 cites·19 claims
- 2061US11608357B2Stabilized antibody protein solutionsARECOR LTD·Filed 2019·Granted Mar 21, 2023·0 cites·47 claims
- 2161US2023414753A1Stabilized antibody protein solutionsARECOR LTD·Filed 2023·Application pending·0 cites
- 2260US11534403B2Liquid pharmaceutical compositionARECOR LTD·Filed 2018·Granted Dec 27, 2022·0 cites·23 claims
- 2359US2022265788A1Aqueous solution compositions for increasing stability of engineered dimeric proteinsARECOR LTD·Filed 2022·Application pending·0 cites
- 2459US2023277453A1Stabilized antibody protein solutionsARECOR LTD·Filed 2023·Application pending·0 cites
- 2559US2025241981A1Novel compositionARECOR LTD·Filed 2025·Application pending·0 cites
- 2659US2021283259A1Protein formulationsARECOR LTD·Filed 2021·Application pending·0 cites
- 2758US2025302745A1Compositions comprising vancomycinARECOR LTD·Filed 2023·Application pending·0 cites
- 2858US2025352610A1Novel compositionARECOR LTD·Filed 2023·Application pending·0 cites
- 2957US2022288165A1Novel composition comprising antibodiesARECOR LTD·Filed 2020·Application pending·0 cites
- 3056US2024166718A1Aqueous composition of an engineered protein construct comprising an fc domainARECOR LTD·Filed 2022·Application pending·0 cites
- 3155US2025049923A1Novel compositionARECOR LTD·Filed 2022·Application pending·0 cites
- 3254US9744242B2Stable aqueous formulations of adenovirus vectorsARECOR LTD·Filed 2016·Granted Aug 29, 2017·0 cites·22 claims
- 3353US2009148406A1Stable Aqueous Systems Comprising ProteinsARECOR LTD·Filed 2006·Application pending·0 cites
- 3452US2025268987A1FormulationsARECOR LTD·Filed 2025·Application pending·0 cites
- 3552US2020093894A1Novel formulationsARECOR LTD·Filed 2018·Application pending·0 cites
- 3648US2022080023A1Novel compositionARECOR LTD·Filed 2019·Application pending·0 cites
- 3748US2023181675A1Novel formuationsARECOR LTD·Filed 2021·Application pending·0 cites
- 3845US2020069799A1Stabilized antibody protein solutionsARECOR LTD·Filed 2019·Application pending·0 cites
- 3945US2021113763A1Medical infusion pump system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Application pending·0 cites
- 4045US2021093775A1Medical infusion pump system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Application pending·0 cites
- 4144US2020023062A1Stabilized antibody protein solutionsARECOR LTD·Filed 2018·Application pending·0 cites
- 4243US2022125718A1STABILIZED Fc FUSION PROTEIN SOLUTIONSARECOR LTD·Filed 2020·Application pending·0 cites
- 4342US12527845B2FormulationsARECOR LTD·Filed 2017·Granted Jan 20, 2026·0 cites·51 claims
- 4441US2020093895A1Stable insulin formulationsARECOR LTD·Filed 2018·Application pending·0 cites
- 4540US2019183980A1Insulin glargineARECOR LTD·Filed 2017·Application pending·0 cites
- 4640US2019175737A1Insulin glargine and triethylenetetramine (teta)ARECOR LTD·Filed 2017·Application pending·0 cites
- 4740US2020023061A1Stabilized antibody solutionsARECOR LTD·Filed 2018·Application pending·0 cites
- 4838US2020222508A1Glucagon-like peptide 1 (glp-1) receptor agonist compositionsARECOR LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →